Source: Health Canada shortage reports · Updated Sep 2, 2026
Some Vardenafil products are in shortage in Canada (2 of 14 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Oct 13, 2026.
A PDE5 inhibitor used to treat erectile dysfunction.
Products affected
2 / 14
In shortage since
Jun 1, 2026
Est. full return
Oct 13, 2026
Reports on file
42
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
MYLAN-VARDENAFIL
20MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02464233 · since Jun 1, 2026, est. end Sep 15, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-VARDENAFIL
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02464209 · since Jun 1, 2026, est. end Oct 13, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP-VARDENAFIL
20MG · TABLET · JAMP PHARMA CORPORATION
DIN 02475693 · ended Jun 26, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-VARDENAFIL
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02464209 · ended Oct 21, 2025 · Demand increase for the drug.
Resolved
MYLAN-VARDENAFIL
10MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02464225 · ended Sep 11, 2025 · Shortage of an active ingredient.
Resolved
VARDENAFIL
20MG · TABLET · SANIS HEALTH INC
DIN 02520400 · ended Jun 23, 2025 · Disruption of the manufacture of the drug.
Resolved
VARDENAFIL
10MG · TABLET · SANIS HEALTH INC
DIN 02520397 · ended Jun 23, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-VARDENAFIL
20MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02464233 · ended May 30, 2025 · Shortage of an active ingredient.
Resolved
MYLAN-VARDENAFIL
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02464209 · ended May 23, 2025 · Shortage of an active ingredient.
Avoided
VARDENAFIL
10MG · TABLET · SANIS HEALTH INC
DIN 02520397 · ended Feb 28, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-VARDENAFIL
5MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02464209 · ended Sep 1, 2023 · Disruption of the manufacture of the drug.
Discontinued
STAXYN
10MG · TABLET (ORALLY DISINTEGRATING) · BAYER INC
DIN 02372436
Showing 12 of 42 reports. All reports are on file with Health Canada.
What's happening
Vardenafil is currently affected by 2 active shortage reports filed with Health Canada by MYLAN PHARMACEUTICALS ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Vardenafil is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BE).
Recent changes
Sep 2, 2026
Estimated end date pushed back : Sep 8, 2026 → Sep 15, 2026
Aug 24, 2026
New report filed
Aug 24, 2026
New report filed
Common questions
What is Vardenafil used for?
A PDE5 inhibitor used to treat erectile dysfunction.
When will Vardenafil be back in stock in Canada?
The latest manufacturer estimate is Oct 13, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Vardenafil in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.